CTOs on the Move

Fenergo

www.fenergo.com

 
Fenergo is an award-winning provider of enterprise Client Lifecycle Management platform solutions designed to help financial institutions to manage the end-to-end regulatory onboarding process - from onboarding, to management of client and counterparty data and regulatory compliance with existing and emerging regulations.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.fenergo.com
  • 77 Summer Street 3rd Floor
    Boston, MA USA 02110
  • Phone: 617.778.6065

Executives

Name Title Contact Details

Similar Companies

Vanguard Software Corp

Vanguard Software Corp is a Cary, NC-based company in the Software and Internet sector.

Vicinity Manufacturing

Vicinity Manufacturing is a Marietta, GA-based company in the Software and Internet sector.

Lawton Software

Lawton Software is a Foresthill, CA-based company in the Software and Internet sector.

Velocify

Velocify is a market-leading provider of cloud-based intelligent sales software, designed for high-velocity sales environments. Velocify helps sales teams keep pace with the speed of opportunity and increase revenue by driving rapid lead response, increased selling discipline, improved productivity, and actionable selling insights. The company has helped more than 1,500 companies across a variety of industries improve customer acquisition practices and sales performance. Velocify was recently recognized as one of the fastest growing companies in North America by Deloitte and a Best Place to Work by the Los Angeles Business Journal.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.